Oral almotriptan in the treatment of migraine: Safety and tolerability

Headache

Volumn 41, Issue 5, 2001, Pages 449-455

  Dodick, David W ^a  

^a MAYO CLINIC   (United States)

Author keywords

5 HTIB ID receptor agonist; Adverse events; Almotriptan; Migraine; Safety; Subcutaneous; Sumatriptan; Tolerability

Indexed keywords

ALMOTRIPTAN; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MIGRAINE; NAUSEA; NORMAL HUMAN; PARESTHESIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

ADMINISTRATION, ORAL; ADULT; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDOLES; MALE; META-ANALYSIS; MIDDLE AGED; MIGRAINE DISORDERS; SAFETY; SEROTONIN AGONISTS; TRYPTAMINES;

EID: 0035016376     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.01082.x     Document Type: Article

References (8)

1. 3 receptor agents. Pharmacol Rev. 1991;43:579-586.
2. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994;47:622-651.
3. Lloyd K. The clinical profile of sumatriptan: safety and tolerability. Eur Neurol. 1994;34(suppl 2):40-43.
4. Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia. 1996;16:554-559.
5. Lewis PJ, Barrington SF, Marsen PK, Maisey MN, Lewis LD. A study of the effects of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH3 positron emission tomography. Neurology. 1997;48:1542-1550.
6. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98:25-30.
7. Blau JN. Adult migraine: the patient observed. In: Blau JN, ed. Migraine. London: Chapman & Hall; 1987:3-30.
8. Dahlöf C, Ekhom K, Persson L. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. Arch Neurol. 1994;51:1256-1261.